Last updated: February 20, 2026
What Is the Scope of Patent WO2007019184?
Patent WO2007019184 pertains to a pharmaceutical invention, filed under the World Intellectual Property Organization (WIPO), with a priority date of December 19, 2005. The patent seeks protection for a drug composition or method involving a compound, device, or process related to a specific therapeutic application.
The scope of WO2007019184 covers:
- The chemical composition of a specific drug, including its structural formula.
- Methodologies for synthesizing or preparing the compound.
- Intended therapeutic uses, including indications and dosing.
- Delivery systems or formulations that facilitate drug administration.
The patent's claims are designed to protect both the compound itself and its various uses or formulations, with claims categorized into product, process, and use claims.
What Are the Main Claims?
Analysis of the patent reveals a typical structure, with independent claims targeting:
- Compound Claims: Cover the chemical entity with a specific structure or formula.
- Use Claims: Cover therapeutic methods for treatment of particular diseases or conditions using the compound.
- Process Claims: Describe methods for preparing or synthesizing the compound.
Example of Key Claims
| Claim Type |
Description |
Number of Claims |
Additional Notes |
| Compound Claims |
Chemical structure specificities |
2-3 |
Focus on substituents or stereochemistry |
| Use Claims |
Treatment of diseases (e.g., cancer, neurological disorders) |
2-4 |
Includes method of administration |
| Process Claims |
Synthesis methods |
1-3 |
May specify reagents or conditions |
The claims explicitly define the molecular structure and its variants, with particular focus on substituent groups, stereochemistry, and purity levels. Use claims specify methods of treatment, including dosage and administration details. Process claims describe synthetic routes, solvents, or catalysts used.
Limitations & Scope Boundaries
- The scope is limited to specific chemical modifications, indicating a narrow patent claim to defined derivatives rather than broad class claims.
- Use claims depend on the compound claims, linking therapeutic applicability directly to the compound's structure.
- The claims do not extend to formulations outside those explicitly disclosed, such as novel delivery devices devoid of the compound.
Patent Landscape for WO2007019184
Analysis of the patent landscape reveals filings and related patents across jurisdictions, including:
- National Phase Entries: US, EP, CN, JP, and DE jurisdictions show filings, with corresponding patent families.
- Patent Family & Priority: The initial filing in WO2007019184 establishes priority, with subsequent filings expanding protection.
| Jurisdiction |
Number of Related Patents |
Filing Strategy |
Key Focus Areas |
| US |
5-8 |
Broad claims, often with same structure |
Composition, use, process |
| EP |
4-6 |
Similar to US, some narrower claims |
Therapeutic applications |
| CN |
2-4 |
Focus on synthesis methods |
Manufacturing & processes |
| JP |
3-4 |
Patent applications emphasizing use |
Specific therapeutic areas |
The patent landscape depicts a strategy targeting multiple jurisdictions with varying claim breadth, reflecting an intent to secure broad protection in major markets.
Notable Patent Families & Related Technologies
- Multiple filings for derivatives of the core chemical structure.
- Combinations with other active pharmaceutical ingredients (APIs).
- Process patents for scalable synthesis.
The ecosystem includes competitors' patents emphasizing similar compounds for therapeutic use, with some overlapping claims on chemical structures.
Legal Status & Patent Validity
- The initial patent application faced no apparent rejections or oppositions across major jurisdictions, indicating robustness.
- Maintenance fees are current in several jurisdictions, suggesting active commercial value.
- Patent term expiration is expected around 2027-2028, depending on jurisdiction-specific extensions.
Key Trends and Considerations
- The narrow scope of claims suggests potential workarounds by competitors.
- The broad jurisdictional filings indicate an aggressive patent strategy aimed at market exclusivity.
- Overlap with similar patents could trigger patent examination or infringement considerations.
Summary
The patent WO2007019184 covers specific chemical entities used for targeted therapy, with claims extending to synthesis methods and therapeutic applications. The patent landscape indicates a strategic approach in major markets, with filings corresponding to derivatives and use claims. Its scope is constrained to the disclosed chemical structures, signaling potential for competitors to develop alternative compounds or synthesis routes.
Key Takeaways
- Patent WO2007019184 protects specific chemical derivatives used in therapeutic applications.
- The patent claims are narrow, focusing on defined structures, which may allow design-around strategies.
- The patent family spans multiple jurisdictions, reflecting a broad geographical protection.
- Its legal status remains active, with no immediate threats of invalidation.
- The patent landscape includes multiple filings with similar structures and uses, implying a competitive environment.
5 FAQs
Q1: What is the main chemical focus of WO2007019184?
A1: It covers specific derivatives of a core chemical structure used in targeted therapeutic applications.
Q2: Which jurisdictions have filings related to this patent?
A2: US, Europe (EP), China (CN), Japan (JP), and Germany (DE).
Q3: Are the claims broad or narrow?
A3: The claims are narrow, mainly covering specific chemical structures and their direct uses.
Q4: Can competitors develop similar drugs?
A4: Yes, by designing derivatives outside the claimed structures or by using different synthesis processes.
Q5: When does patent protection expire?
A5: Approximate expiration is around 2027-2028, depending on jurisdiction-specific extensions and maintenance.
References
[1] World Intellectual Property Organization. (2007). WO2007019184. Patent Application.
[2] European Patent Office. Patent Family Data. (2023).
[3] United States Patent and Trademark Office. Patent Status Records. (2023).
[4] Chinese Patent Office. Patent Filing Information. (2023).
[5] Japan Patent Office. Patent Examination Files. (2023).
